Prospective cohort study of adults hospitalised with acute COPD exacerbations: SARS-CoV-2-associated patient characteristics and clinical outcomes
C. Hyams (Bristol, United Kingdom), G. Nava (Bristol, United Kingdom), E. Begier (New York, United States), J. Southern (Tadworth, United States), J. King (Bristol, United Kingdom), D. Adegbite (Bristol, United Kingdom), L. Fleming (Bristol, United Kingdom), J. Oliver (Bristol, United Kingdom), J. Nguyen (New York, United States), B. Gessner (New York, United States), J. Mclaughlin (New York, United States), A. Finn (Bristol, United Kingdom), J. Dodd (Bristol, United Kingdom)
Source: International Congress 2022 – Diagnosis, prevention and management of infectious respiratory diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Hyams (Bristol, United Kingdom), G. Nava (Bristol, United Kingdom), E. Begier (New York, United States), J. Southern (Tadworth, United States), J. King (Bristol, United Kingdom), D. Adegbite (Bristol, United Kingdom), L. Fleming (Bristol, United Kingdom), J. Oliver (Bristol, United Kingdom), J. Nguyen (New York, United States), B. Gessner (New York, United States), J. Mclaughlin (New York, United States), A. Finn (Bristol, United Kingdom), J. Dodd (Bristol, United Kingdom). Prospective cohort study of adults hospitalised with acute COPD exacerbations: SARS-CoV-2-associated patient characteristics and clinical outcomes. 2462
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|